The Claim
Sleep deprivation in mice reduces the expression of SIRT1 and FOXO1 in visceral white adipose tissue, leading to downregulation of ATGL and impaired triglyceride hydrolysis.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In mice, lack of sleep decreases levels of SIRT1 and FOXO1 proteins in visceral fat, which causes a reduction in ATGL and a decrease in the breakdown of triglycerides.
See the scientific wording
Sleep deprivation in mice reduces the expression of SIRT1 and FOXO1 in visceral white adipose tissue, which mediates the downregulation of ATGL and impairs triglyceride hydrolysis.
When an animal doesn't sleep, a key regulator called SIRT1 drops in belly fat, which turns off another protein called FOXO1. Without FOXO1, the fat cell stops making the enzyme ATGL, which is needed to break down stored fat. As a result, fat builds up instead of being used for energy.
What the research says
1 studyWhen mice don’t sleep, their belly fat stops breaking down properly because key proteins (SIRT1 and FOXO1) that tell the fat to burn get quieter. Giving them a compound called resveratrol fixes this problem.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.